Recent News

By Category: Research

BioShield projects sees vaccine, treatments successes

Efforts on behalf of the U.S. Department Health and Human Services to ensure that the United States has medical countermeasures (MCMs) available for responding to a chemical, biological, radiological, or nuclear (CBRN) event have been successful in developing the first human vaccine for avian flu, as well as delivering treatments for anthrax (vaccines and therapeutics),  Read More »

Antibodies contribute to Effective Vaccination against Respiratory Infection by Type A Francisella tularensis.

Antibodies contribute to Effective Vaccination against Respiratory Infection by Type A Francisella tularensis. Infect Immun. 2011 Jan 31; Authors: Mara-Koosham G, Hutt JA, Lyons CR, Wu TH Pneumonic tularemia is a life-threatening disease caused by inhalation of the highly infectious intracellular bacterium Francisella tularensis. The most serious form of the disease associated with the type  Read More »

Chemistry Professor’s Work Could Lead to Anthrax Cure

A Wichita State University chemistry professor has been making headway in his research to save the lives of anthrax victims. Associate chemistry professor Jim Bann, working with students in his WSU lab, has developed a new amino acid that could prevent the deadly toxin from killing its victim during an anthrax attack. Bann received a  Read More »

CDC opens Alasakan lab

The Centers for Disease Control and Prevention recently opened a major laboratory in Alaska that has a unit capable of testing for agents such as anthrax and tularemia.

Virtual world to aid Secret Service in fighting bioterror

The Secret Service has recently upgraded its tabletop “Tiny Town” model to a virtual world that will help agents to prepare for threat scenarios like chemical, biological and radiological attacks.